Arthur Greenberg - Net Worth and Insider Trading
Arthur Greenberg Net Worth
The estimated net worth of Arthur Greenberg is at least $322,863 dollars as of 2024-11-13. Arthur Greenberg is the Director of Galectin Therapeutics Inc and owns about 109,445 shares of Galectin Therapeutics Inc (GALT) stock worth over $322,863. Details can be seen in Arthur Greenberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arthur Greenberg has not made any transactions after 2016-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arthur Greenberg
Arthur Greenberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arthur Greenberg owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Arthur Greenberg’s form 4 insider trades.
Insider Ownership Summary of Arthur Greenberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2016-01-05 | director |
Arthur Greenberg Latest Holdings Summary
Arthur Greenberg currently owns a total of 1 stock. Arthur Greenberg owns 109,445 shares of Galectin Therapeutics Inc (GALT) as of January 5, 2016, with a value of $322,863.
Latest Holdings of Arthur Greenberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2016-01-05 | 109,445 | 2.95 | 322,863 |
Holding Weightings of Arthur Greenberg
Arthur Greenberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Arthur Greenberg has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 1,666 shares on January 5, 2016, which cost Arthur Greenberg around $2,866.
Insider Trading History of Arthur Greenberg
- 1
Arthur Greenberg Trading Performance
GuruFocus tracks the stock performance after each of Arthur Greenberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arthur Greenberg is 31.15%. GuruFocus also compares Arthur Greenberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arthur Greenberg within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arthur Greenberg's insider trading performs compared to the benchmark.
Performance of Arthur Greenberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.23 | | | | | |
| Relative Return to S&P 500(%) | 8.43 | | | | | |
Arthur Greenberg Ownership Network
Ownership Network List of Arthur Greenberg
Ownership Network Relation of Arthur Greenberg
Arthur Greenberg Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Arthur Greenberg is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Arthur Greenberg made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 16,300 shares made by Kevin D Freeman , and a net purchase of 4,500 shares made by Zordani Richard A. Jr. .
In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 15,300 shares, with a net purchase of 15,300 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Arthur Greenberg Mailing Address
Above is the net worth, insider trading, and ownership report for Arthur Greenberg. You might contact Arthur Greenberg via mailing address: 7 Wells Avenue, Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
